0.46
-0.1097(-19.23%)
Currency In USD
| Previous Close | 0.57 |
| Open | 0.57 |
| Day High | 0.71 |
| Day Low | 0.45 |
| 52-Week High | 2.45 |
| 52-Week Low | 0.28 |
| Volume | 78.75M |
| Average Volume | 14.33M |
| Market Cap | 166.58M |
| PE | -0.73 |
| EPS | -0.63 |
| Moving Average 50 Days | 0.6 |
| Moving Average 200 Days | 1.25 |
| Change | -0.11 |
If you invested $1000 in Lexicon Pharmaceuticals, Inc. (LXRX) 10 years ago, it would be worth $70.78 as of April 01, 2025 at a share price of $0.461. Whereas If you bought $1000 worth of Lexicon Pharmaceuticals, Inc. (LXRX) shares 5 years ago, it would be worth $258.88 as of April 01, 2025 at a share price of $0.461.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
GlobeNewswire Inc.
Mar 28, 2025 11:30 AM GMT
Lexicon eligible to receive up to $1 billion in upfront and development, regulatory and sales milestone payments, including $75 million in upfront and near-term milestone paymentsTHE WOODLANDS, Texas, March 28, 2025 (GLOBE NEWSWIRE) -- Lexicon Phar
Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
GlobeNewswire Inc.
Mar 07, 2025 1:30 PM GMT
THE WOODLANDS, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Leerink Partners Global Healthcare Conference 2025 in Miami on
Lexicon Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
GlobeNewswire Inc.
Mar 04, 2025 9:15 PM GMT
THE WOODLANDS, Texas, March 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its fourth quarter and full year 2024 financial results on Thursday, March 6, 2025 after the markets clos